Clinical trial reports

  • Which CROs Support Pediatric Phase 3 Trials in Europe, and When Are They Used Most?
  • Which CROs Support European Cell Therapy Phase 1-3 Trials, and Where Is Outsourcing Need Highest?
  • What Drives Phase III Cell Therapy CTIS Timelines?
  • How Fast Are Phase I Nephrology CTIS Reviews and What Shapes Timing?
  • Are Digital Recruitment Channels Still Underused in European Phase III Gastric and Esophageal Cancer Trials?
  • Which Endpoints Are Most Frequently Measured in European Cardiology Phase II & III Trials?
  • Which CROs Support Europe’s Endocrinology Phase III Trials, and When Are They Needed Most?
  • Does PFS Displace OS as the Primary Endpoint in Phase III Lymphoma Trials?
  • Where Is CRO Support Most Needed in European Pancreatic Cancer Phase II & III Trials?
  • Which CROs Are Most Active in European Endometrial Cancer Phase II & Phase III Trials?
  • Which Endpoints Are Measured Most Often in European HCC Phase II & III Trials?
  • At what complexity level are CROs used in European breast cancer trials from 2024 to 2026?